LYTENAVA

LIVE

Serial Number

98180421

Owner

Outlook Therapeutics, Inc.

Attorney

Kelley B. Harrington

Filing Date

Sep 14, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LYTENAVA Trademark

Serial Number: 98180421

LYTENAVA is a trademark filed by Outlook Therapeutics, Inc. on September 14, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Outlook Therapeutics, Inc.

485 Route 1 South, Building F, Suite 320
Iselin, NJ 08830

Entity Type: 03

Legal Representation

Attorney of Record

Kelley B. Harrington

410 trademarks filed View all →

Correspondence Address

Kelley B. Harrington Cooley LLP

1299 Pennsylvania Ave, NW, Suite 700

ATTN: IP Docketing Department

Washington, DC 20004-2400

United States

Trademark Details

Filing Date

September 14, 2023

Registration Date

Not Registered

Published for Opposition

September 3, 2024

Goods & Services

Injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease

Filing History

SOU TEAS EXTENSION RECEIVED

Apr 20, 2026 EEXT

TEAS STATEMENT OF USE RECEIVED

Apr 20, 2026 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 15, 2025 EXRA

SOU EXTENSION 2 GRANTED

Oct 14, 2025 EX2G

SOU EXTENSION 2 FILED

Oct 14, 2025 EXT2

SOU TEAS EXTENSION RECEIVED

Oct 14, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 11, 2025 EXRA

SOU EXTENSION 1 GRANTED

Apr 10, 2025 EX1G

SOU EXTENSION 1 FILED

Apr 10, 2025 EXT1

SOU TEAS EXTENSION RECEIVED

Apr 10, 2025 EEXT

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Mar 19, 2025 EWAF

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 19, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 19, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 19, 2025 REAP

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 29, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 3, 2024 NPUB

PUBLISHED FOR OPPOSITION

Sep 3, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 14, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 26, 2024 CNSA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 14, 2024 GNRN

NON-FINAL ACTION E-MAILED

May 14, 2024 GNRT

NON-FINAL ACTION WRITTEN

May 14, 2024 CNRT

ASSIGNED TO EXAMINER

May 8, 2024 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 3, 2023 NWOS

NEW APPLICATION ENTERED

Sep 18, 2023 NWAP

Related Trademarks

More from this Owner

OUTLOOK THERAPEUTICS

LYTENAVA NAVIGATOR

Serial #97831497

LYTENAVA SPOTLYTE

More in Same Class

RIMU HEALTH PRODUCTS

MAB3